LIGAND PHARMACEUTICALS INCORPORATED Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $74.42 per share for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-23.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2015-02-23
- LIGAND PHARMACEUTICALS INCORPORATED share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2014 was $74.42, a 15.39% decline from fiscal 2013.
- LIGAND PHARMACEUTICALS INCORPORATED share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2013 was $87.96, a 0.00% change from fiscal 2012.
- LIGAND PHARMACEUTICALS INCORPORATED share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2012 was $87.96.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month as first filed |
|---|---|---|
| 2014-12-31 | $74.42 10-K · filed 2015-02-23 | $87.96 10-K · filed 2014-12-01 |
| 2013-12-31 | $87.96 10-K/A · filed 2014-12-12 | |
| 2012-12-31 | $87.96 10-K · filed 2013-03-14 |